Koyfin Home > Directory > Health Care > Adamas Pharma > Cash and Short-Term Investments

Adamas Pharma Cash and Short-Term Investments Chart (ADMS)

Adamas Pharma annual/quarterly Cash and Short-Term Investments from 2012 to 2020.
  • Adamas Pharma Cash and Short-Term Investments for the quarter ending June 06, 2020 was $103m a -45.28% decrease of -47m year over year
  • Adamas Pharma Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $103m a -45.28% decrease of -47m year over year
  • Adamas Pharma Annual Cash and Short-Term Investments for 2019 was $133m a -59.02% decrease of -78m from 2018
  • Adamas Pharma Annual Cash and Short-Term Investments for 2018 was $211m a 17.75% increase of 37m from 2017
  • Adamas Pharma Annual Cash and Short-Term Investments for 2017 was $173m a 34.47% increase of 60m from 2016
Other Balance Sheet Metrics:
  • Adamas Pharma Total Assets for the quarter ending September 09, 2018 was $257m a 27.59% increase of 71m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
  • Adamas Pharma Total Equity for the quarter ending September 09, 2018 was $114m a 42.20% increase of 48m year over year
View Chart On Koyfin

Quarterly ADMS Cash and Short-Term Investments Data

06/2020$103m
03/2020$115m
12/2019$133m
09/2019$150m
06/2019$169m
03/2019$191m
12/2018$211m
09/2018$211m
06/2018$203m
03/2018$199m

Annual ADMS Cash and Short-Term Investments Data

2019$133m
2018$211m
2017$173m
2016$114m
2015$107m
2014$122m
2013$86m
2012$63m
2011$3m